Book Reviews
Stroke: A Practical Guide to Management, 2nd Edition. J.C.P. Wardlow, et al. Blackwell Science, Malden, MA, 2001, 804 pp., illustrated, $199 .00.
For the coagulationist, the problems of hemorrhage and thrombosis in the brain present challenges. Increasingly, the problem has become iatrogenic, but the long history of strokes before anticoagulant and antiplatelet drugs continues to challenge both clinicians and laboratorians. In this second edition, the extensive experience of the seven authors and the growing body of new knowledge gained since the first edition was released in 1996 expose the current understanding of diagnosis and treatment of stroke, the second leading cause of death and the leading cause of disability today. The seven authors (from Great Britain, Netherlands, and Australia) provide the evidence-based analysis of the long history of stroke, which until 1950 was essentially academic and without the effective therapy that emerged, and of recent thrombolytic therapy.
Thrombosis and Thromboembolism (44th in Fundamental and Clinical Cardiology Series). Samuel Z. Goldhaber and Raul M. Ridker (eds.). Marcel Dekker, Inc.,New York, 2002. 365 pp., illustrated, $165.00.
Both the underlying scientific and the clinical progress with thrombosis within the past decade have required timely updating, provided in this new volume. Goldhaber's Prevention of Venous Thromboembolism, published as no. 12 within this same cardiology series in 1993, had already given the coagulationist considerable information; but now has been superseded by this 44th of the series to supply an unmet need within today's community of clinicians and scientists and providing help in controlling this major problem of mankind. The contributors provide concise summaries of controversial matters as they present their own preferences and show where the evidence is weak for decision making.
One extensive chapter considers a subject dear to our hearts (Wehrmacher W, Iqbal 0, Messmore H. Brain attack: who will write the orders for thrombolytics?" Arch Intern Med 2000; 160:119-120) . The contributors support the need for a stroke service, designed for organized available services to facilitate prompt, effective provision of optimal diagnosis and treatment that goes to the core of community and hospital responsibilities. Finally, they consider current procedures for reducing the burden of stroke for patients, their families, and society. Primary prevention is included.
Every laboratorian and physician will find the guidelines in this book helpful. The introduction of low-molecular-weight heparins, novel thienopyridine antagonists of platelet the adenosine diphosphate receptor, and several varieties of glycoprotein lIb/Illa inhibitors has provided attractive new therapies that greatly supplement catheter-directed thrombolysis, percutaneous clot extraction, and surgical embolectomy. Concepts of hypercoagulability and the clinical pharmacology of drugs used in acute coronary syndromes are particularly helpful in this period of rapid accumulation of new data. All of these data need to be brought from the investigators' field to patients' needs, as the 28 contributors to this volume demonstrate. 
